nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—DRD4—conduct disorder	0.616	0.684	CbGaD
Propiomazine—HTR2A—conduct disorder	0.284	0.316	CbGaD
Propiomazine—HTR2A—autonomic nervous system—conduct disorder	0.000657	0.239	CbGeAlD
Propiomazine—Cyamemazine—HTR2A—conduct disorder	0.000479	0.0788	CrCbGaD
Propiomazine—Methotrimeprazine—DRD4—conduct disorder	0.000456	0.0751	CrCbGaD
Propiomazine—Promazine—DRD4—conduct disorder	0.000395	0.065	CrCbGaD
Propiomazine—Chlorpromazine—DRD4—conduct disorder	0.000348	0.0572	CrCbGaD
Propiomazine—DRD4—brain—conduct disorder	0.000324	0.118	CbGeAlD
Propiomazine—Acepromazine—HTR2A—conduct disorder	0.000308	0.0506	CrCbGaD
Propiomazine—Clomipramine—SLC6A4—conduct disorder	0.000304	0.0501	CrCbGaD
Propiomazine—Thioproperazine—HTR2A—conduct disorder	0.000301	0.0495	CrCbGaD
Propiomazine—Thiothixene—HTR2A—conduct disorder	0.000296	0.0487	CrCbGaD
Propiomazine—Pipotiazine—HTR2A—conduct disorder	0.000296	0.0487	CrCbGaD
Propiomazine—Mesoridazine—HTR2A—conduct disorder	0.000292	0.0481	CrCbGaD
Propiomazine—Trimipramine—SLC6A4—conduct disorder	0.00028	0.0461	CrCbGaD
Propiomazine—Fluphenazine—HTR2A—conduct disorder	0.000256	0.0421	CrCbGaD
Propiomazine—CHRM4—brain—conduct disorder	0.000245	0.0892	CbGeAlD
Propiomazine—Clomipramine—HTR2A—conduct disorder	0.000234	0.0385	CrCbGaD
Propiomazine—Chlorprothixene—HTR2A—conduct disorder	0.000233	0.0383	CrCbGaD
Propiomazine—Thioridazine—HTR2A—conduct disorder	0.00022	0.0363	CrCbGaD
Propiomazine—Trimipramine—HTR2A—conduct disorder	0.000215	0.0354	CrCbGaD
Propiomazine—Methotrimeprazine—HTR2A—conduct disorder	0.00021	0.0346	CrCbGaD
Propiomazine—Promethazine—HTR2A—conduct disorder	0.000207	0.0341	CrCbGaD
Propiomazine—Trifluoperazine—HTR2A—conduct disorder	0.000204	0.0336	CrCbGaD
Propiomazine—Perphenazine—HTR2A—conduct disorder	0.000202	0.0333	CrCbGaD
Propiomazine—CHRM5—brain—conduct disorder	0.000191	0.0697	CbGeAlD
Propiomazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000186	0.00206	CbGpPWpGaD
Propiomazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000186	0.00205	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.000185	0.00204	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.000184	0.00203	CbGpPWpGaD
Propiomazine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000184	0.00203	CbGpPWpGaD
Propiomazine—Promazine—HTR2A—conduct disorder	0.000182	0.03	CrCbGaD
Propiomazine—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.000181	0.002	CbGpPWpGaD
Propiomazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000178	0.00197	CbGpPWpGaD
Propiomazine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000177	0.00195	CbGpPWpGaD
Propiomazine—ADRA1B—brain—conduct disorder	0.000175	0.0637	CbGeAlD
Propiomazine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000172	0.0019	CbGpPWpGaD
Propiomazine—ADRA1D—brain—conduct disorder	0.000171	0.0623	CbGeAlD
Propiomazine—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.000171	0.00189	CbGpPWpGaD
Propiomazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000164	0.00181	CbGpPWpGaD
Propiomazine—DRD1—brain—conduct disorder	0.000163	0.0594	CbGeAlD
Propiomazine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000162	0.00179	CbGpPWpGaD
Propiomazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000162	0.00178	CbGpPWpGaD
Propiomazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000161	0.00178	CbGpPWpGaD
Propiomazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000161	0.00177	CbGpPWpGaD
Propiomazine—Chlorpromazine—HTR2A—conduct disorder	0.00016	0.0264	CrCbGaD
Propiomazine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00016	0.00177	CbGpPWpGaD
Propiomazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000159	0.00176	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—CGA—conduct disorder	0.000159	0.00176	CbGpPWpGaD
Propiomazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000159	0.00175	CbGpPWpGaD
Propiomazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000158	0.00175	CbGpPWpGaD
Propiomazine—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000158	0.00174	CbGpPWpGaD
Propiomazine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000157	0.00173	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—CGA—conduct disorder	0.000157	0.00173	CbGpPWpGaD
Propiomazine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000155	0.00172	CbGpPWpGaD
Propiomazine—CHRM4—GPCR ligand binding—DRD4—conduct disorder	0.000155	0.00172	CbGpPWpGaD
Propiomazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000155	0.00171	CbGpPWpGaD
Propiomazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000153	0.00168	CbGpPWpGaD
Propiomazine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00015	0.00166	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—CGA—conduct disorder	0.00015	0.00166	CbGpPWpGaD
Propiomazine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000149	0.00164	CbGpPWpGaD
Propiomazine—CHRM5—GPCR ligand binding—DRD4—conduct disorder	0.000149	0.00164	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—CGA—conduct disorder	0.000144	0.00159	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000143	0.00158	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—CGA—conduct disorder	0.000142	0.00157	CbGpPWpGaD
Propiomazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000142	0.00157	CbGpPWpGaD
Propiomazine—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000142	0.00157	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.000141	0.00156	CbGpPWpGaD
Propiomazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000141	0.00155	CbGpPWpGaD
Propiomazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00014	0.00155	CbGpPWpGaD
Propiomazine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00014	0.00155	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00014	0.00155	CbGpPWpGaD
Propiomazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000138	0.00153	CbGpPWpGaD
Propiomazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000138	0.00152	CbGpPWpGaD
Propiomazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000138	0.00152	CbGpPWpGaD
Propiomazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000137	0.00151	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—CGA—conduct disorder	0.000136	0.00151	CbGpPWpGaD
Propiomazine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000136	0.0015	CbGpPWpGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000136	0.0015	CbGpPWpGaD
Propiomazine—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000136	0.0015	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000136	0.0015	CbGpPWpGaD
Propiomazine—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.000135	0.00149	CbGpPWpGaD
Propiomazine—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000135	0.00149	CbGpPWpGaD
Propiomazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000134	0.00148	CbGpPWpGaD
Propiomazine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000134	0.00147	CbGpPWpGaD
Propiomazine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000133	0.00147	CbGpPWpGaD
Propiomazine—CHRM2—brain—conduct disorder	0.000131	0.0479	CbGeAlD
Propiomazine—DRD1—Signaling by GPCR—CGA—conduct disorder	0.00013	0.00144	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.000128	0.00142	CbGpPWpGaD
Propiomazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000128	0.00141	CbGpPWpGaD
Propiomazine—HTR2C—brain—conduct disorder	0.000127	0.0461	CbGeAlD
Propiomazine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000122	0.00135	CbGpPWpGaD
Propiomazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000122	0.00134	CbGpPWpGaD
Propiomazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000122	0.00134	CbGpPWpGaD
Propiomazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000121	0.00134	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000121	0.00134	CbGpPWpGaD
Propiomazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000121	0.00134	CbGpPWpGaD
Propiomazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000121	0.00133	CbGpPWpGaD
Propiomazine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00012	0.00132	CbGpPWpGaD
Propiomazine—CHRM1—brain—conduct disorder	0.00012	0.0436	CbGeAlD
Propiomazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000119	0.00132	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000117	0.00129	CbGpPWpGaD
Propiomazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000116	0.00128	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000116	0.00128	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000111	0.00123	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000108	0.00119	CbGpPWpGaD
Propiomazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000107	0.00118	CbGpPWpGaD
Propiomazine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.00118	CbGpPWpGaD
Propiomazine—CHRM3—brain—conduct disorder	0.000107	0.039	CbGeAlD
Propiomazine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000106	0.00118	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.00117	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.00117	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.00117	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.000105	0.00116	CbGpPWpGaD
Propiomazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.00116	CbGpPWpGaD
Propiomazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.00116	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.00116	CbGpPWpGaD
Propiomazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.00116	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.00116	CbGpPWpGaD
Propiomazine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.00115	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.00115	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.000104	0.00115	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000104	0.00115	CbGpPWpGaD
Propiomazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000104	0.00115	CbGpPWpGaD
Propiomazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000103	0.00114	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.000103	0.00114	CbGpPWpGaD
Propiomazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000103	0.00114	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000103	0.00114	CbGpPWpGaD
Propiomazine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	0.000103	0.00114	CbGpPWpGaD
Propiomazine—DRD4—Circadian rythm related genes—EP300—conduct disorder	0.000102	0.00113	CbGpPWpGaD
Propiomazine—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	0.000101	0.00112	CbGpPWpGaD
Propiomazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.95e-05	0.0011	CbGpPWpGaD
Propiomazine—ADRA1A—brain—conduct disorder	9.83e-05	0.0358	CbGeAlD
Propiomazine—DRD2—Signaling by GPCR—CGA—conduct disorder	9.82e-05	0.00108	CbGpPWpGaD
Propiomazine—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	9.71e-05	0.00107	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	9.66e-05	0.00107	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—CGA—conduct disorder	9.64e-05	0.00106	CbGpPWpGaD
Propiomazine—DRD2—brain—conduct disorder	9.63e-05	0.0351	CbGeAlD
Propiomazine—CHRM1—Signaling by GPCR—CGA—conduct disorder	9.61e-05	0.00106	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—CGA—conduct disorder	9.58e-05	0.00106	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—CGA—conduct disorder	9.48e-05	0.00105	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	9.46e-05	0.00104	CbGpPWpGaD
Propiomazine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	9.26e-05	0.00102	CbGpPWpGaD
Propiomazine—DRD1—Circadian rythm related genes—EP300—conduct disorder	9.18e-05	0.00101	CbGpPWpGaD
Propiomazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.18e-05	0.00101	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	9.13e-05	0.00101	CbGpPWpGaD
Propiomazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.01e-05	0.000995	CbGpPWpGaD
Propiomazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.98e-05	0.000992	CbGpPWpGaD
Propiomazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.95e-05	0.000988	CbGpPWpGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.87e-05	0.000979	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.84e-05	0.000976	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	8.79e-05	0.00097	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CGA—conduct disorder	8.53e-05	0.000942	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CGA—conduct disorder	8.42e-05	0.000929	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	8.41e-05	0.000929	CbGpPWpGaD
Propiomazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.35e-05	0.000922	CbGpPWpGaD
Propiomazine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	8.2e-05	0.000905	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CGA—conduct disorder	8.06e-05	0.00089	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	8.02e-05	0.000885	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—DRD4—conduct disorder	7.98e-05	0.000881	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	7.92e-05	0.000874	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	7.91e-05	0.000873	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CGA—conduct disorder	7.68e-05	0.000848	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—DRD4—conduct disorder	7.64e-05	0.000844	CbGpPWpGaD
Propiomazine—HRH1—brain—conduct disorder	7.61e-05	0.0277	CbGeAlD
Propiomazine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	7.58e-05	0.000837	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CGA—conduct disorder	7.58e-05	0.000837	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—DRD4—conduct disorder	7.28e-05	0.000804	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	7.18e-05	0.000793	CbGpPWpGaD
Propiomazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	6.99e-05	0.000772	CbGpPWpGaD
Propiomazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	6.93e-05	0.000765	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	6.86e-05	0.000758	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.86e-05	0.000757	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	6.84e-05	0.000755	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—WASF1—conduct disorder	6.84e-05	0.000755	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	6.82e-05	0.000753	CbGpPWpGaD
Propiomazine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	6.78e-05	0.000749	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—CGA—conduct disorder	6.77e-05	0.000747	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	6.75e-05	0.000745	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—WASF1—conduct disorder	6.75e-05	0.000745	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	6.73e-05	0.000743	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CGA—conduct disorder	6.57e-05	0.000725	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	6.57e-05	0.000725	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—WASF1—conduct disorder	6.46e-05	0.000713	CbGpPWpGaD
Propiomazine—HTR2A—brain—conduct disorder	6.35e-05	0.0231	CbGeAlD
Propiomazine—ADRA1B—Signaling Pathways—CGA—conduct disorder	6.29e-05	0.000694	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	6.23e-05	0.000688	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—WASF1—conduct disorder	6.16e-05	0.00068	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	6.07e-05	0.00067	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	6.05e-05	0.000668	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	5.96e-05	0.000658	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.96e-05	0.000658	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	5.94e-05	0.000656	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	5.92e-05	0.000654	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	5.91e-05	0.000652	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	5.85e-05	0.000646	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	5.83e-05	0.000644	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	5.81e-05	0.000641	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CGA—conduct disorder	5.8e-05	0.00064	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	5.73e-05	0.000633	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CGA—conduct disorder	5.71e-05	0.00063	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CGA—conduct disorder	5.69e-05	0.000629	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CGA—conduct disorder	5.68e-05	0.000626	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CGA—conduct disorder	5.66e-05	0.000624	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CGA—conduct disorder	5.6e-05	0.000618	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CGA—conduct disorder	5.59e-05	0.000617	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	5.5e-05	0.000607	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	5.49e-05	0.000606	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	5.41e-05	0.000597	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—DRD4—conduct disorder	5.4e-05	0.000596	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	5.38e-05	0.000594	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	5.36e-05	0.000592	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	5.31e-05	0.000586	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	5.3e-05	0.000585	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	5.28e-05	0.000583	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—WASF1—conduct disorder	5.27e-05	0.000581	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	5.23e-05	0.000577	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	5.21e-05	0.000575	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	5.16e-05	0.00057	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	5.04e-05	0.000556	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	4.99e-05	0.00055	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	4.75e-05	0.000524	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—DRD4—conduct disorder	4.71e-05	0.00052	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	4.69e-05	0.000517	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—WASF1—conduct disorder	4.65e-05	0.000513	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.57e-05	0.000505	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—WASF1—conduct disorder	4.56e-05	0.000504	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—WASF1—conduct disorder	4.55e-05	0.000502	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—WASF1—conduct disorder	4.53e-05	0.0005	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—DRD4—conduct disorder	4.51e-05	0.000498	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—WASF1—conduct disorder	4.49e-05	0.000496	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	4.48e-05	0.000494	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	4.48e-05	0.000494	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—DRD4—conduct disorder	4.3e-05	0.000475	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	4.28e-05	0.000473	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	4.24e-05	0.000468	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	4.06e-05	0.000449	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.95e-05	0.000436	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.89e-05	0.000429	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.88e-05	0.000428	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.87e-05	0.000427	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	3.85e-05	0.000425	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	3.82e-05	0.000421	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.81e-05	0.00042	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.68e-05	0.000406	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.59e-05	0.000396	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	3.52e-05	0.000389	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	3.52e-05	0.000389	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	3.51e-05	0.000388	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	3.5e-05	0.000386	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	3.47e-05	0.000383	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	3.46e-05	0.000381	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DRD4—conduct disorder	3.25e-05	0.000358	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	3.2e-05	0.000353	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD4—conduct disorder	3.19e-05	0.000352	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD4—conduct disorder	3.18e-05	0.000351	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD4—conduct disorder	3.17e-05	0.00035	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD4—conduct disorder	3.14e-05	0.000346	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	3.13e-05	0.000345	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HTR2A—conduct disorder	3.12e-05	0.000344	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	3.08e-05	0.000339	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—COMT—conduct disorder	3.05e-05	0.000337	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—MAOA—conduct disorder	3.03e-05	0.000335	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	2.95e-05	0.000325	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.81e-05	0.00031	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.77e-05	0.000306	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.4e-05	0.000265	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	2.3e-05	0.000254	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.12e-05	0.000234	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR2A—conduct disorder	2.08e-05	0.00023	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	2.07e-05	0.000229	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	2.07e-05	0.000228	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	2.05e-05	0.000226	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	2.04e-05	0.000225	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—EP300—conduct disorder	1.65e-05	0.000182	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—EP300—conduct disorder	1.63e-05	0.00018	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—EP300—conduct disorder	1.56e-05	0.000172	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—EP300—conduct disorder	1.49e-05	0.000164	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.47e-05	0.000162	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—EP300—conduct disorder	1.31e-05	0.000145	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.27e-05	0.00014	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.22e-05	0.000134	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EP300—conduct disorder	1.12e-05	0.000124	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.1e-05	0.000122	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EP300—conduct disorder	1.1e-05	0.000122	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EP300—conduct disorder	1.1e-05	0.000121	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EP300—conduct disorder	1.1e-05	0.000121	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EP300—conduct disorder	1.08e-05	0.00012	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.08e-05	0.000119	CbGpPWpGaD
